Arab Health 2015, a great success for Penlon
18th February 2015
Arab Health is an important annual event for Penlon, as we welcome existing distributors and new customers from across the Middle East, Asia and Africa. We were in a prime location in the main exhibition hall, with an exciting new stand design that looked great and worked well. We had a continuous flow of passing traffic and visitors to the stand, generating a record number of leads for new business and potential commercial partnerships.
Products on display included our new range of anaesthesia and intubation equipment for MRI applications. Penlon continues to innovate in the field of medical devices for anaesthesia and our stand featured new solutions for anaesthetic agent delivery—in vaporizer design and workstation systems such as the Dual CGO option for the Prima 400 Series.
For the third consecutive year the Prima 460 Anaesthesia System was used in the Surgical Simulation Area of the ABHI’s (Association of British Healthcare Industries) stand.
This year’s show attracted 87,450 visitors from over 150 countries. Nearly 3750 companies exhibited so we were pleased to be included in the official day-one highlights video posted by the Arab Health team on YouTube (click here to see the clip, look for Penlon around 30 seconds into the video).
“Arab Health 2015 looks to be our most successful show in recent years. The number of enquiries taken this year exceeded the previous years' totals after only three days. Thank you to everybody involved for their hard work, without whom the show would not have been as successful.”
Peter Worrallo (Sales and Marketing Director)
Arab Health took place January 26th – 29th, 2015 at the Dubai International Convention & Exhibition Centre.
Penlon is a long established medical device company, with headquarters and manufacturing facilities based in Abingdon, UK. The key areas of business are Anaesthesia, Intubation, Suction and Oxygen Therapy and these are supported by our experienced Technical Service team. Penlon has a presence in over 90 countries worldwide.